Finn John 4
4 · Trius Therapeutics Inc · Filed Apr 26, 2013
Insider Transaction Report
Form 4
Finn John
Chief Scientific Officer
Transactions
- Sale
Common Stock
2013-04-24$7.10/sh−500$3,550→ 189,860 total(indirect: By Trust)
Holdings
- 1,782
Common Stock
Footnotes (1)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 21, 2012.